Research Mental Health and Society

Health Technology Assessment in Primary Care and Mental Health (PRISMA)

Research Program

Mental Health and Society

Leaders

Where we are

Parc Sanitari Sant Joan de Déu

How to reach us

Professional network profiles

Related websites

We conduct research into the design and evaluation of new technologies and health services, with a special focus on primary and community care and mental health. As a research group, we focus on health economics including exploring preventive strategies and pharmacological/non-pharmacological treatments for mental health disorders and other chronic diseases that are either extremely prevalent or have a major social impact, such as stroke and cardiovascular disease.

We also evaluate the health impact of population interventions, policies or access to resources, and the use of health and social services. The results of these studies can be used in health service planning, economic management and to establish health policies.

We were part of the Cooperative Research Network for Research on Health Outcomes and Health Services (IRYSS, G03/202) between 2003 and 2005. From 2007 to 2021 the group was part of the Research in Preventive Activities and Health Promotion network (redIAPP, RD12 / 0005/008), which in 2022 was transformed into the RICAPPS, where it is also part of (RD21/0016/0018). Some members of our group joined the Centre for Biomedical Research Network for Epidemiology and Public Health (CIBERESP) (CB16 / 02/00322) in 2017. Our group has been recognised as a consolidated research group by AGAUR (SGR 1515).

Project

"NHoA - Never Home Alone" Principal Investigator: Dr. Antoni Serrano Blanco. 2021-2024. The PLEC2021-007868 project has been funded by MCIN/AEI/10.13039/501100011033 and by the European Union Next Generation EU/PRTR; within the call "R+D+i projects in «strategic lines» 2021"

Research lines

  1. Research in Primary and Community Care (Principal investigator: Maria Rubio): we carry out and evaluate the effectiveness and efficiency of health interventions in primary and community care involving professionals and patients through qualitative and quantitative studies (epidemiological, Real World Data and clinical trials). 
  2. Evaluation of health services (Principal investigator: Antoni Serrano): we explore the availability and efficiency of health services, with special emphasis on the economic assessment of diseases, by carrying out cost/burden of disease studies and interventions, through cost-effectiveness studies based on clinical trials and economic models.

Scientific objectives

  1. To develop and evaluate interventions to improve initiation of pharmacological treatments in primary care.
  2. To study the impact of social events on the behaviour of patients and professionals and their health impact through natural experiments.
  3. To evaluate the efficiency (effectiveness and cost-effectiveness) of preventive and therapeutic interventions in primary care and other settings.
  4. To assess the stigma associated with mental health and the effectiveness of population-based interventions aimed at curbing this.

Area/Field of expertise

The group includes psychiatrists, GPs, pharmacists, psychologists and economists who provide a global perspective on the studies being carried out. We have methodological experts with extensive experience in health economics and quantitative and qualitative research.

Our primary objective is to guide health decision-making by researching the efficiency of health technologies in primary care, with a special focus on health prevention and promotion, mental health therapies and medication adherence. We also seek to detect needs and generate interventions based on expertise taking into account the context in which they are to be implemented. We, therefore, also conduct studies on the prevalence of mental illness, the coordination between different levels of care, the cost and burden of the disease and the classification and mapping of services.

To answer these highly complex questions, we employ mixed research methods and have expertise in qualitative research, clinical trials, Real World Data, cost-effectiveness studies based on clinical trials and mathematical models as well as other methodologies. Finally, the group includes professionals with a strong statistical background who apply cutting-edge statistical techniques to the analysis of our study results.

Group members

Last Publications

More Publications

Projects

Project name:
Motius en la cronificació de l’Ús de Benzodiazepines: Estudi Qualitatiu (Estudi B-LONG)
Leader
Maria Montserrat Gil Girbau
Funding entities:
Provincia San Juan de Dios de España
Code
PFNR0207
Starting - finishing date:
2024 - 2025
Project name:
M-AES_Estancia en Center of Research in Pharmacoeconomics and Drug utilization (CIRFF) at University of Naples Federico Il
Leader
Ignacio Aznar Lou
Funding entities:
Instituto de Salud Carlos III (ISCIII)
Code
MV23/00027
Starting - finishing date:
2024 - 2024
Project name:
SALVOVAR : A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVES
Leader
Alexandra Lelia Dima
Funding entities:
European Commission
Code
101104469
Starting - finishing date:
2023 - 2028
More projects

Theses

  • Adaptació al mitjà penitenciari d’homes amb psicosi. Validació de l’escala “Prison Adjustment Index” en població masculina amb psicosi
    Author
    Cañete Mena, Gustavo Adolfo
    Institution
    UNIVERSIDAD AUTÓNOMA DE BARCELONA
    03/12/2024
  • Problemas de Adherencia al Inicio de Tratamientos para la Enfermedad Cardiovascular y Diabetes
    Author
    Vilaplana Carnerero, Carles
    Institution
    UNIVERSIDAD DE BARCELONA
    17/09/2020
  • El problema de la no iniciación del tratamiento farmacológico: evaluación con métodos cualitativos
    Author
    Gil Girbau, Maria Montserrat
    Institution
    UNIVERSIDAD DE BARCELONA
    14/01/2020
More Theses

News

See All news

More activities

More activities